Datium (MDCX)

IEO

Last updated: Oct 03, 2024

Datium is the first database of healthcare data processed by its exclusive Xilo Arificial Intelligence system that use Proof of Brain to validate transactions and where patients and Healthcare professionals can monetize their experiences and information, receiving $MDCx as a reward for their interaction.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Project industry	Big Data & Data Storage / Health & Medicine / BNB Chain Ecosystem
Product type	Platform
Founded	Argentina
Whitepaper	Open

What is Datium

The combination of the Collective Knowledge Protocol with the Proof of Brain Validation System and $MDCx as a means of compensation for mining, makes the Datium/MDCx ecosystem the new development paradigm of the crypto-blockchain economy. Its initial use in the health sector allows for rapid growth and expansion of use by its users and participating agents, but we understand that due to its power and simplicity, in a short time it will be of standard use for all human activities and industries related to information and its use as a critical decision mechanism.

MDCx the first health token that uses industry data as an asset which gives value to the coin.

This token can be used as a reward instrument, means of payment in the DATIUM Ecosystem, or as an investment vehicle.

The data obtained through DATIUM, the first database with healthcare data processed by its exclusive Xilo® Artificial Intelligence system, is tokenized and valued in MDCx.

Details

IEO (Latoken Launchpad): Oct 01, 2024 - Oct 30, 2024
Token supply: 200,000,000 MDCX
Hard cap: 10,000,000 USD

Legal

Blockchain Platform: Binance Smart Chain
Registration year: 2020

Token info

Ticker: MDCX
Type: Utility-token
Token standard: BEP20
Token price in USD: 1 MDCX = 0.07 - 0.12 USD
Accepted currencies: BNB, USDT

Datium Roadmap

2020 - Foundation of Datium.info

Q1 2020: Datium.info is founded, a company dedicated to revolutionizing the healthcare industry through disruptive technologies like artificial intelligence (Al) and blockchain.
Q4 2020: The development of the MDCx ecosystem begins, aimed at tokenizing health data and creating decentralized applications (DApps) focused on the medical and pharmaceutical sectors.

2021 - Conceptualization and Design

Q2 2021: The Datium ecosystem is structured, integrating blockchain and Al technologies. The technical infrastructure to handle secure medical data begins development.
Q3 2021: Initial design and development of Medbot, a clinical simulation platform powered by Al that generates clinical cases and offers metanalyses of medical reports.
Q4 2021: Conceptualization of CureMD, a telemedicine and health insurance platform, and IntelliHealth, an Al assistant for medical professionals.

2022 - Infrastructure Development

Q1 2022: Development begins for the CureMD platform, focused on telemedicine and preventive healthcare.
Q2 2022: Ongoing development of Medbot and IntelliHealth, with internal testing to optimize the user experience for medical professionals.
Q4 2022: Initial conceptualization and development of Remedyx, a marketplace for purchasing pharmaceutical products directly from laboratories.

2023 - Launch of CureMD

Q1 2023: Launch of the CureMD DApp, offering telemedicine, online medical consultations, and healthcare services, all payable using MDCx.
Q2 2023: CureMD expands in Latin America, adding services such as psychological and nutritional assistance, and access to discounted medications.
Q3 2023: Medbot is officially launched for healthcare professionals, allowing users to earn MDCx by solving clinical cases.
Q4 2023: Remedyx goes live, offering a decentralized marketplace for pharmaceutical products, featuring Al-driven inventory and sales management.

2024 - Strategic Partnerships and Growth

Q1 2024: CureMD partners with a major insurance company, launching a comprehensive health insurance plan, covering emergencies, surgeries, and preventive medical care, all accessible through MDCx.
Q2 2024: Medbot expands with advanced tools for clinical simulation and data analysis, becoming a key educational platform in the medical field.
Q3 2024: Remedyx broadens its customer base with direct commercial agreements with laboratories in Europe and North America.
Q4 2024: IntelliHealth integrates loT devices for remote patient monitoring and offers automated triage services to clinics in the U.S.

2025 - Innovation and New Markets

Q1 2025: MDCx becomes a key payment method for digital health services in various countries, integrating hospitals and healthcare centers.
Q3 2025: Medbot introduces an advanced medical education platform, collaborating with universities and medical research centers for professional training.
Q4 2025: CureMD and Remedyx expand into new markets, establishing a presence in Europe and Asia through partnerships with local governments and companies.

2026 - Ecosystem Consolidation

Q1 2026: CureMD becomes one of the leading digital health insurance platforms, offering additional prevention and wellness services.
Q2 2026: MDCx is adopted as a mainstream payment token in international health systems, allowing access to consultations, treatments, and medications in various countries.
Q4 2026: Datium.info launches version 3.0 of its ecosystem, connecting all DApps (CureMD, Medbot, IntelliHealth, and Remedyx) for complete interoperability, maximizing the use and monetization of health data through MDCx